US5993850A
(en)
*
|
1994-09-13 |
1999-11-30 |
Skyepharma Inc. |
Preparation of multivesicular liposomes for controlled release of encapsulated biologically active substances
|
US6428771B1
(en)
*
|
1995-05-15 |
2002-08-06 |
Pharmaceutical Discovery Corporation |
Method for drug delivery to the pulmonary system
|
US5931809A
(en)
*
|
1995-07-14 |
1999-08-03 |
Depotech Corporation |
Epidural administration of therapeutic compounds with sustained rate of release
|
DE69717661T2
(de)
*
|
1996-09-13 |
2003-09-25 |
Lipoxen Technologies Ltd |
Liposomenzusammensetzung
|
US7384923B2
(en)
|
1999-05-14 |
2008-06-10 |
Lipoxen Technologies Limited |
Liposomes
|
CN1241902A
(zh)
*
|
1996-10-25 |
2000-01-19 |
孟山都公司 |
用外源化学物质处理植物的组合物和方法
|
JP4155601B2
(ja)
*
|
1996-10-25 |
2008-09-24 |
モンサント・テクノロジー・エルエルシー |
外因性化学物質で植物を処理するための組成物および方法
|
US6544523B1
(en)
|
1996-11-13 |
2003-04-08 |
Chiron Corporation |
Mutant forms of Fas ligand and uses thereof
|
EP0948538B1
(de)
|
1996-12-13 |
2008-06-11 |
Novartis Vaccines and Diagnostics, Inc. |
Analyse und separation von pdgf-proteinen
|
US5891467A
(en)
*
|
1997-01-31 |
1999-04-06 |
Depotech Corporation |
Method for utilizing neutral lipids to modify in vivo release from multivesicular liposomes
|
US6106858A
(en)
*
|
1997-09-08 |
2000-08-22 |
Skyepharma, Inc. |
Modulation of drug loading in multivescular liposomes
|
JP4467789B2
(ja)
*
|
1997-09-18 |
2010-05-26 |
パシラ ファーマシューティカルズ インコーポレーテッド |
持続放出性リポソーム麻酔組成物
|
US6914131B1
(en)
|
1998-10-09 |
2005-07-05 |
Chiron S.R.L. |
Neisserial antigens
|
CA2671261A1
(en)
|
1997-11-06 |
1999-05-20 |
Novartis Vaccines And Diagnostics S.R.L. |
Neisserial antigens
|
CA2309548A1
(en)
|
1997-11-14 |
1999-05-27 |
Skyepharma Inc. |
Production of multivesicular liposomes
|
BR9906927A
(pt)
|
1998-01-14 |
2001-11-20 |
Chiron Spa |
Proteìnas de neisseria meningitidis
|
NZ541361A
(en)
|
1998-05-01 |
2008-04-30 |
Inst Genomic Research |
Neisseria meningitidis antigens and compositions relating to SEQ ID Nos:2916, 2918 and 2920
|
EP1953229A3
(de)
|
1998-10-15 |
2008-12-24 |
Novartis Vaccines and Diagnostics, Inc. |
Metastatische Brust- und Dickdarmkrebs-regulierte Gene
|
DK1141331T3
(da)
|
1998-12-16 |
2009-01-05 |
Novartis Vaccines & Diagnostic |
Human cyclinafhængig kinase (hPNQALRE)
|
AU781703B2
(en)
*
|
1999-01-25 |
2005-06-09 |
Blue Ridge Pharmaceuticals, Inc. |
Liposome formulations
|
MXPA01010924A
(es)
|
1999-04-30 |
2002-05-06 |
Chiron Spa |
Antigenos de neisseria conservados.
|
GB9911683D0
(en)
|
1999-05-19 |
1999-07-21 |
Chiron Spa |
Antigenic peptides
|
WO2001000654A2
(en)
|
1999-06-29 |
2001-01-04 |
Pharmaceutical Discovery Corporation |
Purification and stabilization of peptide and proteins in pharmaceutical agents
|
US9006175B2
(en)
*
|
1999-06-29 |
2015-04-14 |
Mannkind Corporation |
Potentiation of glucose elimination
|
GB9916529D0
(en)
|
1999-07-14 |
1999-09-15 |
Chiron Spa |
Antigenic peptides
|
EP2275553B1
(de)
|
1999-10-29 |
2015-05-13 |
Novartis Vaccines and Diagnostics S.r.l. |
Antigenpeptide aus Neisseria
|
AU1922101A
(en)
|
1999-11-18 |
2001-05-30 |
Chiron Corporation |
Human fgf-21 gene and gene expression products
|
CA2395314A1
(en)
|
1999-12-23 |
2001-11-15 |
Neurochem, Inc. |
Compounds and methods for modulating cerebral amyloid angiopathy
|
ES2507100T3
(es)
|
2000-01-17 |
2014-10-14 |
Novartis Vaccines And Diagnostics S.R.L. |
Vacuna OMV suplementada contra meningococo
|
BR0108711A
(pt)
|
2000-02-28 |
2004-06-22 |
Chiron Spa |
Expressão heteróloga de proteìnas de neisseria
|
EP1261638A2
(de)
|
2000-03-08 |
2002-12-04 |
Chiron Corporation |
Humanes fgf-23 gen und genexpressionsprodukte
|
EP1950297A2
(de)
|
2000-05-31 |
2008-07-30 |
Novartis Vaccines and Diagnostics, Inc. |
Zusammensetzungen und Verfahren zur Behandlung neoplastischer Erkrankungen mithilfe von Chemotherapie und Strahlungssensibilisatoren
|
US7700359B2
(en)
|
2000-06-02 |
2010-04-20 |
Novartis Vaccines And Diagnostics, Inc. |
Gene products differentially expressed in cancerous cells
|
EP1953243B1
(de)
|
2000-06-15 |
2012-12-26 |
Novartis Vaccines and Diagnostics, Inc. |
Polynukleotide im Zusammenhang mit Darmkrebs
|
NZ560966A
(en)
|
2000-10-27 |
2010-06-25 |
Novartis Vaccines & Diagnostic |
Nucleic acids and proteins from streptococcus groups A & B
|
JP2004535765A
(ja)
|
2000-12-07 |
2004-12-02 |
カイロン コーポレイション |
前立腺癌においてアップレギュレートされた内因性レトロウイルス
|
GB0107658D0
(en)
|
2001-03-27 |
2001-05-16 |
Chiron Spa |
Streptococcus pneumoniae
|
GB0107661D0
(en)
|
2001-03-27 |
2001-05-16 |
Chiron Spa |
Staphylococcus aureus
|
AU2002258728A1
(en)
|
2001-04-06 |
2002-10-21 |
Georgetown University |
Gene brcc-3 and diagnostic and therapeutic uses thereof
|
WO2002081639A2
(en)
|
2001-04-06 |
2002-10-17 |
Georgetown University |
Gene brcc2 and diagnostic and therapeutic uses thereof
|
WO2002081641A2
(en)
|
2001-04-06 |
2002-10-17 |
Georgetown University |
Gene scc-112 and diagnostic and therapeutic uses thereof
|
KR20030022094A
(ko)
|
2001-05-24 |
2003-03-15 |
(주)휴먼디엔에이테크놀로지 |
모낭에 존재하는 새로운 제 2 케라티노사이트 성장인자유사체
|
CN100398551C
(zh)
|
2001-11-09 |
2008-07-02 |
乔治敦大学 |
新的血管内皮细胞生长抑制剂同种型
|
KR100982204B1
(ko)
|
2001-12-12 |
2010-09-14 |
노바티스 백신즈 앤드 다이아그노스틱스 에스.알.엘. |
클라미디아 트라코마티스에 대한 면역화
|
ES2323456T3
(es)
|
2002-01-08 |
2009-07-16 |
Novartis Vaccines And Diagnostics, Inc. |
Productos genicos diferencialmente expresados en celulas de pecho cancerosas y sus metodos de uso.
|
EP1572933A4
(de)
|
2002-02-13 |
2007-09-05 |
Univ Duke |
Modulation der immunantwort durch polypeptide als antwort auf nichtpeptidischen bindungsstress
|
FR2836043B1
(fr)
*
|
2002-02-15 |
2004-06-04 |
Inst Nat Sante Rech Med |
Vesicules lipidiques, preparation et utilisations
|
DE60318938T2
(de)
|
2002-03-20 |
2009-01-22 |
Mannkind Corp., Valencia |
Inhalationsgerät
|
WO2003080808A2
(en)
|
2002-03-21 |
2003-10-02 |
Sagres Discovery, Inc. |
Novel compositions and methods in cancer
|
US20040082521A1
(en)
*
|
2002-03-29 |
2004-04-29 |
Azaya Therapeutics Inc. |
Novel formulations of digitalis glycosides for treating cell-proliferative and other diseases
|
US7244565B2
(en)
|
2002-04-10 |
2007-07-17 |
Georgetown University |
Gene shinc-3 and diagnostic and therapeutic uses thereof
|
US8518694B2
(en)
|
2002-06-13 |
2013-08-27 |
Novartis Vaccines And Diagnostics, Inc. |
Nucleic acid vector comprising a promoter and a sequence encoding a polypeptide from the endogenous retrovirus PCAV
|
US20040001889A1
(en)
|
2002-06-25 |
2004-01-01 |
Guohua Chen |
Short duration depot formulations
|
US20050169979A1
(en)
*
|
2002-07-03 |
2005-08-04 |
Dov Michaeli |
Liposomal vaccine
|
CA2489919A1
(en)
*
|
2002-07-03 |
2004-01-15 |
Aphton Corporation |
Liposomal vaccine
|
US20040247661A1
(en)
*
|
2002-07-03 |
2004-12-09 |
Dov Michaeli |
Liposomal vaccine
|
US7135324B2
(en)
|
2002-09-04 |
2006-11-14 |
The University Of Connecticut |
Viral recombinases, related articles, and methods of use thereof
|
UA80447C2
(en)
|
2002-10-08 |
2007-09-25 |
|
Methods for treating pain by administering nerve growth factor antagonist and opioid analgesic
|
US7179484B2
(en)
*
|
2002-11-06 |
2007-02-20 |
Azaya Therapeutics, Inc. |
Protein-stabilized liposomal formulations of pharmaceutical agents
|
DK2279746T3
(da)
|
2002-11-15 |
2013-11-25 |
Novartis Vaccines & Diagnostic |
Overfladeproteiner i neisseria meningitidis
|
US9498530B2
(en)
|
2002-12-24 |
2016-11-22 |
Rinat Neuroscience Corp. |
Methods for treating osteoarthritis pain by administering a nerve growth factor antagonist and compositions containing the same
|
CA2921578C
(en)
|
2002-12-24 |
2017-02-14 |
Rinat Neuroscience Corp. |
Anti-ngf antibodies and methods using same
|
US7569364B2
(en)
|
2002-12-24 |
2009-08-04 |
Pfizer Inc. |
Anti-NGF antibodies and methods using same
|
CA2516138A1
(en)
|
2003-02-14 |
2004-09-02 |
Sagres Discovery, Inc. |
Therapeutic gpcr targets in cancer
|
US7767387B2
(en)
|
2003-06-13 |
2010-08-03 |
Sagres Discovery, Inc. |
Therapeutic targets in cancer
|
EP1594441B1
(de)
|
2003-02-19 |
2010-12-15 |
Rinat Neuroscience Corp. |
Verfahren zur behandlung von schmerzen durch verabreichung eines nervenwachstumsfaktor-antagonisten und eines nsaid und diese enthaltende zusammensetzung
|
GB0308198D0
(en)
|
2003-04-09 |
2003-05-14 |
Chiron Srl |
ADP-ribosylating bacterial toxin
|
CA2536393A1
(en)
*
|
2003-09-09 |
2005-06-16 |
Gilead Sciences, Inc. |
Use of liposomes which are small unilamellar vesicles for the removal of an entity from a biological sample
|
BRPI0417270A
(pt)
|
2003-12-23 |
2007-03-27 |
Rinat Neuroscience Corp |
anticorpos agonistas antitrkc e métodos para utilização dos mesmos
|
AU2005204378B2
(en)
*
|
2004-01-12 |
2009-01-22 |
Mannkind Corporation |
A method of reducing serum proinsulin levels in type 2 diabetics
|
US20080248999A1
(en)
*
|
2007-04-04 |
2008-10-09 |
Biodel Inc. |
Amylin formulations
|
US20080090753A1
(en)
|
2004-03-12 |
2008-04-17 |
Biodel, Inc. |
Rapid Acting Injectable Insulin Compositions
|
DK1736541T3
(da)
|
2004-03-29 |
2013-05-06 |
Galpharma Co Ltd |
Nyt modificeret galectin 9-protein og anvendelse heraf
|
US7223562B2
(en)
|
2004-03-31 |
2007-05-29 |
New York University |
Compositions for controlling hair growth
|
KR20060135060A
(ko)
|
2004-04-07 |
2006-12-28 |
리나트 뉴로사이언스 코퍼레이션 |
신경성장인자 길항제의 투여에 의한 골암 통증의 치료방법
|
US20050255154A1
(en)
*
|
2004-05-11 |
2005-11-17 |
Lena Pereswetoff-Morath |
Method and composition for treating rhinitis
|
ES2309766T3
(es)
*
|
2004-06-04 |
2008-12-16 |
Camurus Ab |
Formulaciones liquidas de liberacion lenta.
|
AU2005327194B2
(en)
|
2004-07-09 |
2010-09-09 |
The Henry M. Jackson Foundation For The Advancement Of Military Medicine, Inc. |
Soluble forms of Hendra and Nipah virus G glycoprotein
|
US20060024677A1
(en)
|
2004-07-20 |
2006-02-02 |
Morris David W |
Novel therapeutic targets in cancer
|
EP2298807A3
(de)
|
2004-07-30 |
2011-05-18 |
Rinat Neuroscience Corp. |
Gegen das Amyloid-beta-Peptid gerichtete Antikörper und Verfahren zu deren Anwendung
|
DK1786784T3
(da)
|
2004-08-20 |
2011-02-14 |
Mannkind Corp |
Katalyse af diketopiperazinsyntese
|
JP4990142B2
(ja)
|
2004-08-23 |
2012-08-01 |
マンカインド コーポレイション |
薬物送達のためのジケトピペラジン塩、ジケトモルホリン塩、又はジケトジオキサン塩
|
DE05852057T1
(de)
|
2004-11-23 |
2007-11-29 |
Neuromolecular Pharmaceuticals Inc., Emeryville |
Zusammensetzung aus einer beschichtung oder matrix mit verzögerter freisetzung und einem nmda-rezeptorantagonisten sowie verfahren zur verabreichung eines solchen nmda-rezeptorantagonisten an ein subjekt
|
US7619007B2
(en)
|
2004-11-23 |
2009-11-17 |
Adamas Pharmaceuticals, Inc. |
Method and composition for administering an NMDA receptor antagonist to a subject
|
WO2006058236A2
(en)
|
2004-11-24 |
2006-06-01 |
Neuromolecular Pharmaceuticals, Inc. |
Composition comprising an nmda receptor antagonist and levodopa and use thereof for treating neurological disease
|
US7939490B2
(en)
|
2004-12-13 |
2011-05-10 |
University Of Maryland, Baltimore |
TWEAK as a therapeutic target for treating central nervous system diseases associated with cerebral edema and cell death
|
EP1858919B1
(de)
|
2005-02-18 |
2012-04-04 |
Novartis Vaccines and Diagnostics, Inc. |
Immungene von uropathogenen escherichia coli
|
DE602006016934D1
(de)
|
2005-04-06 |
2010-10-28 |
Adamas Pharmaceuticals Inc |
Verfahren und zusammensetzungen zur behandlung von zns-erkrankungen
|
WO2006110599A2
(en)
|
2005-04-07 |
2006-10-19 |
Novartis Vaccines And Diagnostics Inc. |
Cacna1e in cancer diagnosis, detection and treatment
|
JP2008535853A
(ja)
|
2005-04-07 |
2008-09-04 |
ノバルティス ヴァクシンズ アンド ダイアグノスティクス インコーポレイテッド |
癌関連遺伝子
|
JP4997239B2
(ja)
|
2005-07-22 |
2012-08-08 |
ワイズ・エー・シー株式会社 |
抗cd26抗体およびその使用方法
|
US20070110674A1
(en)
*
|
2005-07-29 |
2007-05-17 |
Yuhong Xu |
Sono-active liposomes and lipid particles and use thereof as contrast agents and active-agent delivery systems
|
HUE028691T2
(en)
|
2005-09-14 |
2016-12-28 |
Mannkind Corp |
A method for formulating a drug based on increasing the affinity of crystalline microparticle surfaces towards active ingredients
|
US8084420B2
(en)
|
2005-09-29 |
2011-12-27 |
Biodel Inc. |
Rapid acting and long acting insulin combination formulations
|
WO2007041481A1
(en)
*
|
2005-09-29 |
2007-04-12 |
Biodel, Inc. |
Rapid acting and prolonged acting insulin preparations
|
US7713929B2
(en)
*
|
2006-04-12 |
2010-05-11 |
Biodel Inc. |
Rapid acting and long acting insulin combination formulations
|
SI2380592T1
(en)
|
2005-11-14 |
2018-06-29 |
Teva Pharmaceuticals International Gmbh |
The antibody to the calcitonin-related peptide antagonist
|
US20070154546A1
(en)
*
|
2005-12-30 |
2007-07-05 |
Zhang Jack Y |
Sustained release pharmaceutical compositions
|
AU2007216966C1
(en)
|
2006-02-22 |
2014-03-20 |
Mannkind Corporation |
A method for improving the pharmaceutic properties of microparticles comprising diketopiperazine and an active agent
|
AU2007238114B2
(en)
|
2006-04-12 |
2010-10-14 |
Biodel, Inc. |
Rapid acting and long acting insulin combination formulations
|
SG172684A1
(en)
|
2006-06-07 |
2011-07-28 |
Bioalliance Cv |
Antibodies recognizing a carbohydrate containing epitope on cd-43 and cea expressed on cancer cells and methods using same
|
EP2035035A2
(de)
|
2006-06-09 |
2009-03-18 |
Novartis AG |
Immunogene zusammensetzungen für streptococcus agalactiae
|
JP2010500399A
(ja)
|
2006-08-16 |
2010-01-07 |
ノバルティス アーゲー |
尿路病原性大腸菌由来の免疫原
|
EP2134365B1
(de)
|
2007-03-21 |
2019-03-13 |
Effat Emamian |
Zusammensetzung und verfahren zur hemmung von zellwachstum
|
WO2008124176A2
(en)
|
2007-04-10 |
2008-10-16 |
The Administrators Of The Tulane Educational Fund |
Soluble and membrane-anchored forms of lassa virus subunit proteins
|
GB0714963D0
(en)
|
2007-08-01 |
2007-09-12 |
Novartis Ag |
Compositions comprising antigens
|
US8785396B2
(en)
|
2007-10-24 |
2014-07-22 |
Mannkind Corporation |
Method and composition for treating migraines
|
WO2009077993A2
(en)
|
2007-12-17 |
2009-06-25 |
Pfizer Limited |
Treatment of interstitial cystitis
|
ES2550757T3
(es)
|
2007-12-18 |
2015-11-12 |
Bioalliance C.V. |
Anticuerpos que reconocen un epítopo que contiene carbohidratos en CD43 y ACE expresados en células cancerosas y métodos de uso de los mismos
|
JP2011516078A
(ja)
|
2008-04-10 |
2011-05-26 |
セル・シグナリング・テクノロジー・インコーポレイテツド |
癌におけるegfr突然変異を検出する組成物および方法
|
CN102112110A
(zh)
*
|
2008-06-06 |
2011-06-29 |
米尔纳医疗股份有限公司 |
用于RNAi试剂体内递送的新型组合物
|
ES2655921T3
(es)
|
2008-06-13 |
2018-02-22 |
Mannkind Corporation |
Un inhalador de polvo seco y sistema para administración de fármacos
|
WO2009150623A1
(en)
|
2008-06-13 |
2009-12-17 |
Pfizer Inc |
Treatment of chronic prostatitis
|
US8485180B2
(en)
|
2008-06-13 |
2013-07-16 |
Mannkind Corporation |
Dry powder drug delivery system
|
ES2904623T3
(es)
|
2008-06-20 |
2022-04-05 |
Mannkind Corp |
Aparato interactivo para establecer un perfil en tiempo real de esfuerzos de inhalación
|
TWI532497B
(zh)
|
2008-08-11 |
2016-05-11 |
曼凱公司 |
超快起作用胰島素之用途
|
TWI516501B
(zh)
|
2008-09-12 |
2016-01-11 |
禮納特神經系統科學公司 |
Pcsk9拮抗劑類
|
AU2009302042A1
(en)
*
|
2008-10-07 |
2010-04-15 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem, Ltd. |
Liposomal systems comprising sphingomyelin
|
US8314106B2
(en)
|
2008-12-29 |
2012-11-20 |
Mannkind Corporation |
Substituted diketopiperazine analogs for use as drug delivery agents
|
WO2010086828A2
(en)
|
2009-02-02 |
2010-08-05 |
Rinat Neuroscience Corporation |
Agonist anti-trkb monoclonal antibodies
|
US9060927B2
(en)
|
2009-03-03 |
2015-06-23 |
Biodel Inc. |
Insulin formulations for rapid uptake
|
ES2733084T3
(es)
|
2009-03-06 |
2019-11-27 |
Glaxosmithkline Biologicals Sa |
Antígenos de Chlamydia
|
EP2405963B1
(de)
|
2009-03-11 |
2013-11-06 |
MannKind Corporation |
Gerät, system und verfahren zur messung von widerstand in einem inhaliergerät
|
WO2010118243A2
(en)
|
2009-04-08 |
2010-10-14 |
Genentech, Inc. |
Use of il-27 antagonists to treat lupus
|
BRPI1013780B8
(pt)
|
2009-04-14 |
2022-10-04 |
Novartis Ag |
Composição imunogênica útil para imunização contra staphylococcus aureus, seu método de preparação e composição farmacêutica
|
WO2010138918A1
(en)
*
|
2009-05-29 |
2010-12-02 |
Pacira Pharmaceuticals, Inc. |
Hyaluronidase as an adjuvant for increasing the injection volume and dispersion of large diameter synthetic membrane vesicles containing a therapeutic agent
|
WO2010144789A2
(en)
|
2009-06-12 |
2010-12-16 |
Mannkind Corporation |
Diketopiperazine microparticles with defined specific surface areas
|
WO2010146511A1
(en)
|
2009-06-17 |
2010-12-23 |
Pfizer Limited |
Treatment of overactive bladder
|
CA2768343A1
(en)
|
2009-07-16 |
2011-01-20 |
Novartis Ag |
Detoxified escherichia coli immunogens
|
WO2011056889A1
(en)
|
2009-11-03 |
2011-05-12 |
Mannkind Corporation |
An apparatus and method for simulating inhalation efforts
|
GB0919690D0
(en)
|
2009-11-10 |
2009-12-23 |
Guy S And St Thomas S Nhs Foun |
compositions for immunising against staphylococcus aureus
|
AU2010325960C1
(en)
|
2009-12-02 |
2015-08-06 |
Adamas Pharma, Llc |
Amantadine compositions and methods of use
|
TWI596114B
(zh)
|
2010-02-24 |
2017-08-21 |
雷那特神經科學股份有限公司 |
拮抗劑抗-il-7受體抗體及方法
|
GB201003333D0
(en)
|
2010-02-26 |
2010-04-14 |
Novartis Ag |
Immunogenic proteins and compositions
|
MX2012010481A
(es)
|
2010-03-11 |
2012-10-09 |
Rinat Neuroscience Corp |
Anticuerpos con union de antigenos dependiente del ph.
|
GB201005625D0
(en)
|
2010-04-01 |
2010-05-19 |
Novartis Ag |
Immunogenic proteins and compositions
|
WO2011133931A1
(en)
|
2010-04-22 |
2011-10-27 |
Genentech, Inc. |
Use of il-27 antagonists for treating inflammatory bowel disease
|
US9770414B2
(en)
|
2010-05-13 |
2017-09-26 |
Pacira Pharmaceuticals, Inc. |
Sustained release formulation of methotrexate as a disease-modifying antirheumatic drug (DMARD) and an anti-cancer agent
|
KR20130117755A
(ko)
|
2010-06-21 |
2013-10-28 |
맨카인드 코포레이션 |
건조 분말 약물 운반 시스템 및 방법
|
JP2013533286A
(ja)
|
2010-07-30 |
2013-08-22 |
セントルイス ユニバーシティ |
疼痛を治療する方法
|
JP6194248B2
(ja)
*
|
2010-10-28 |
2017-09-06 |
パシラ ファーマシューティカルズ インコーポレーテッド |
非ステロイド性抗炎症薬の徐放性処方物
|
WO2012072769A1
(en)
|
2010-12-01 |
2012-06-07 |
Novartis Ag |
Pneumococcal rrgb epitopes and clade combinations
|
EP2630953B1
(de)
*
|
2010-12-27 |
2017-08-09 |
Terumo Kabushiki Kaisha |
Liposomzusammensetzung und herstellungsverfahren dafür
|
CA2821995C
(en)
|
2011-01-06 |
2019-02-12 |
Bionor Immuno As |
Monomeric and multimeric peptides immunogenic against hiv
|
US10842849B2
(en)
|
2011-02-28 |
2020-11-24 |
The Schepens Eye Research Institute, Inc. |
Methods for promoting neuronal outgrowth by insulin-like growth factor binding protein-like 1 (IGFBPL-1) in glaucoma or leber's optic neuropathy
|
CN105667994B
(zh)
|
2011-04-01 |
2018-04-06 |
曼金德公司 |
用于药物药盒的泡罩包装
|
WO2012174472A1
(en)
|
2011-06-17 |
2012-12-20 |
Mannkind Corporation |
High capacity diketopiperazine microparticles
|
US20130071375A1
(en)
|
2011-08-22 |
2013-03-21 |
Saint Louis University |
Compositions and methods for treating inflammation
|
WO2013028527A1
(en)
|
2011-08-23 |
2013-02-28 |
Indiana University Research And Technology Corporation |
Compositions and methods for treating cancer
|
WO2013063160A1
(en)
|
2011-10-24 |
2013-05-02 |
Mannkind Corporation |
Methods and compositions for treating pain
|
RU2480479C1
(ru)
*
|
2011-11-01 |
2013-04-27 |
Елена Викторовна Свирщевская |
Гетерологичный пептидный мини-антиген в составе полимерной частицы для создания противоаллергенной вакцины
|
SG11201401699WA
(en)
|
2011-11-11 |
2014-09-26 |
Rinat Neuroscience Corp |
Antibodies specific for trop-2 and their uses
|
WO2013093693A1
(en)
|
2011-12-22 |
2013-06-27 |
Rinat Neuroscience Corp. |
Staphylococcus aureus specific antibodies and uses thereof
|
CN104169301A
(zh)
|
2011-12-22 |
2014-11-26 |
瑞纳神经科学公司 |
人生长激素受体拮抗剂抗体及其使用方法
|
WO2013168167A1
(en)
|
2012-05-10 |
2013-11-14 |
Painreform Ltd. |
Depot formulations of a hydrophobic active ingredient and methods for preparation thereof
|
FR2991196B1
(fr)
*
|
2012-05-29 |
2014-06-27 |
Capsum |
Nanoparticules ciblantes pour une application biologique
|
CN104619727B
(zh)
|
2012-06-25 |
2019-04-05 |
布里格姆及妇女医院股份有限公司 |
靶向治疗
|
US20150191702A1
(en)
|
2012-07-02 |
2015-07-09 |
Commonwealth Scientific And Industrial Research Organization |
Paramyxovirus and Methods of Use
|
CN108057154B
(zh)
|
2012-07-12 |
2021-04-16 |
曼金德公司 |
干粉药物输送系统和方法
|
EP2877155B1
(de)
|
2012-07-26 |
2020-10-28 |
Camurus AB |
Opioid-formulierungen
|
US8603470B1
(en)
|
2012-08-07 |
2013-12-10 |
National Cheng Kung University |
Use of IL-20 antagonists for treating liver diseases
|
US10159644B2
(en)
|
2012-10-26 |
2018-12-25 |
Mannkind Corporation |
Inhalable vaccine compositions and methods
|
BR112015010722A2
(pt)
|
2012-11-09 |
2017-08-22 |
Pfizer |
Anticorpos específicos de fator de crescimento derivado de plaquetas de isoforma b e composições e usos dos mesmos
|
RU2018137673A
(ru)
|
2012-11-30 |
2019-03-22 |
Глаксосмитклайн Байолоджикалс Са |
Антигены и комбинации антигенов pseudomonas
|
KR20160029731A
(ko)
|
2013-03-12 |
2016-03-15 |
더 제너럴 하스피탈 코포레이션 |
변형된 뮐러관 억제 물질(mis) 단백질 및 질환 치료를 위한 그 용도
|
CN105051051B
(zh)
|
2013-03-15 |
2021-07-16 |
萨瑞斯治疗控股公司 |
用于合成神经鞘磷脂和二氢神经鞘磷脂的方法
|
JP6499155B2
(ja)
|
2013-03-15 |
2019-04-10 |
ロマ リンダ ユニバーシティ |
自己免疫疾患の治療
|
JP6523247B2
(ja)
|
2013-03-15 |
2019-05-29 |
マンカインド コーポレイション |
微結晶性ジケトピペラジン粒子の製造方法および乾燥粉末組成物の製造方法
|
US9708354B2
(en)
|
2013-03-15 |
2017-07-18 |
Cerenis Therapeutics Holding Sa |
Methods for the synthesis of sphingomyelins and dihydrosphingomyelins
|
US20160017055A1
(en)
|
2013-03-15 |
2016-01-21 |
Dyax Corp. |
Anti-plasma kallikrein antibodies
|
CN105189560A
(zh)
|
2013-05-07 |
2015-12-23 |
瑞纳神经科学公司 |
抗胰高血糖素受体抗体和其使用方法
|
US10154971B2
(en)
|
2013-06-17 |
2018-12-18 |
Adamas Pharma, Llc |
Methods of administering amantadine
|
US10208125B2
(en)
|
2013-07-15 |
2019-02-19 |
University of Pittsburgh—of the Commonwealth System of Higher Education |
Anti-mucin 1 binding agents and uses thereof
|
EP3021834A1
(de)
|
2013-07-18 |
2016-05-25 |
MannKind Corporation |
Hitzestabile pharmazeutische trockenpulverzusammensetzungen und verfahren
|
FR3008900B1
(fr)
*
|
2013-07-25 |
2018-03-30 |
Centre Nat Rech Scient |
Nanoparticules lipidiques multicompartimentees
|
TWI623551B
(zh)
|
2013-08-02 |
2018-05-11 |
輝瑞大藥廠 |
抗cxcr4抗體及抗體-藥物結合物
|
EP3030294B1
(de)
|
2013-08-05 |
2020-10-07 |
MannKind Corporation |
Insufflationsvorrichtung
|
SG10201810298VA
(en)
|
2013-11-13 |
2018-12-28 |
Pfizer |
Tumor necrosis factor-like ligand 1a specific antibodies and compositions and uses thereof
|
WO2015087187A1
(en)
|
2013-12-10 |
2015-06-18 |
Rinat Neuroscience Corp. |
Anti-sclerostin antibodies
|
JP2017504589A
(ja)
|
2013-12-11 |
2017-02-09 |
ザ ジェネラル ホスピタル コーポレイション |
避妊および卵巣予備能の保存のためのミュラー管抑制物質(mis)タンパク質の使用
|
WO2015109212A1
(en)
|
2014-01-17 |
2015-07-23 |
Pfizer Inc. |
Anti-il-2 antibodies and compositions and uses thereof
|
PE20220337A1
(es)
|
2014-03-21 |
2022-03-14 |
Teva Pharmaceuticals Int Gmbh |
Anticuerpos antagonistas dirigidos contra el peptido relacionado con el gen de calcitonina y metodos que usan los mismos
|
US10307464B2
(en)
|
2014-03-28 |
2019-06-04 |
Mannkind Corporation |
Use of ultrarapid acting insulin
|
EP3785700A1
(de)
|
2014-04-21 |
2021-03-03 |
Heron Therapeutics, Inc. |
Zusammensetzungen aus einem polyorthoester und einem organischen sauren trägerstoff
|
US9801945B2
(en)
|
2014-04-21 |
2017-10-31 |
Heron Therapeutics, Inc. |
Long-acting polymeric delivery systems
|
PL3134068T3
(pl)
|
2014-04-21 |
2021-12-20 |
Heron Therapeutics, Inc. |
Polimerowe układy do dostarczania leków o przedłużonym uwalnianiu
|
WO2018048460A1
(en)
|
2014-04-21 |
2018-03-15 |
Heron Therapeutics, Inc. |
A pharmaceutical composition comprising a delivery system, an amide-type local anesthetic, and meloxicam
|
EP3139955B1
(de)
|
2014-04-30 |
2024-03-20 |
President and Fellows of Harvard College |
Fusionsproteine zur behandlung von krebs und zugehörige verfahren
|
US9840553B2
(en)
|
2014-06-28 |
2017-12-12 |
Kodiak Sciences Inc. |
Dual PDGF/VEGF antagonists
|
US10561806B2
(en)
|
2014-10-02 |
2020-02-18 |
Mannkind Corporation |
Mouthpiece cover for an inhaler
|
TWI595006B
(zh)
|
2014-12-09 |
2017-08-11 |
禮納特神經系統科學公司 |
抗pd-1抗體類和使用彼等之方法
|
GB2541835B
(en)
*
|
2015-01-21 |
2018-09-12 |
Pacira Pharmaceuticals Inc |
Multivesicular liposome formulations of tranexamic acid
|
US9758575B2
(en)
|
2015-04-06 |
2017-09-12 |
Yung Shin Pharmaceutical Industrial Co. Ltd. |
Antibodies which specifically bind to canine vascular endothelial growth factor and uses thereof
|
TWI787645B
(zh)
|
2015-04-13 |
2022-12-21 |
美商輝瑞股份有限公司 |
Cd3特異性抗體、治療性雙特異性抗體及其用途
|
US10877045B2
(en)
|
2015-07-21 |
2020-12-29 |
Saint Louis University |
Compositions and methods for diagnosing and treating endometriosis-related infertility
|
MX2018000714A
(es)
|
2015-07-21 |
2019-11-18 |
Dyax Corp |
Un inhibidor de anticuerpo monoclonal de factor xiia.
|
US11066481B2
(en)
|
2015-07-23 |
2021-07-20 |
The Regents Of The University Of California |
Antibodies to coagulation factor XIa and uses thereof
|
KR20230074843A
(ko)
|
2015-08-19 |
2023-05-31 |
화이자 인코포레이티드 |
조직 인자 경로 억제제 항체 및 그의 용도
|
IL305148A
(en)
|
2015-09-15 |
2023-10-01 |
Scholar Rock Inc |
Anti-pro/hidden myostatin antibodies and their uses
|
US10138298B2
(en)
|
2015-10-23 |
2018-11-27 |
The Regents Of The University Of California |
Anti-IL-2 antibodies and compositions and uses thereof
|
WO2017075037A1
(en)
|
2015-10-27 |
2017-05-04 |
Scholar Rock, Inc. |
Primed growth factors and uses thereof
|
CN106699889A
(zh)
|
2015-11-18 |
2017-05-24 |
礼进生物医药科技(上海)有限公司 |
抗pd-1抗体及其治疗用途
|
US10973783B2
(en)
|
2015-12-30 |
2021-04-13 |
Adamas Pharmaceuticals, Inc. |
Methods and compositions for the treatment of seizure-related disorders
|
CA3010056A1
(en)
|
2015-12-30 |
2017-07-06 |
Kodiak Sciences Inc. |
Antibodies and conjugates thereof
|
WO2017125831A1
(en)
|
2016-01-21 |
2017-07-27 |
Pfizer Inc. |
Mono and bispecific antibodies for epidermal growth factor receptor variant iii and cd3 and their uses
|
EP3541815A4
(de)
|
2016-11-18 |
2020-07-15 |
Pacira Pharmaceuticals, Inc. |
Multivesikuläre liposomenformulierung mit zinkmeloxicamkomplex-mikropartikeln und verfahren zur herstellung davon
|
KR102069670B1
(ko)
*
|
2017-03-02 |
2020-01-23 |
단디바이오사이언스 주식회사 |
면역활성물질을 포함하는 다중도메인캡슐, 이의 제조방법, 및 이를 포함하는 면역조절 조성물
|
KR20190124753A
(ko)
|
2017-03-03 |
2019-11-05 |
리나트 뉴로사이언스 코프. |
항-gitr 항체 및 이의 사용 방법
|
US20200056190A1
(en)
|
2017-03-16 |
2020-02-20 |
Pfizer Inc. |
Tyrosine prototrophy
|
WO2018191548A2
(en)
|
2017-04-14 |
2018-10-18 |
Kodiak Sciences Inc. |
Complement factor d antagonist antibodies and conjugates thereof
|
WO2018200885A1
(en)
|
2017-04-26 |
2018-11-01 |
Neurocentria, Inc. |
Magnesium compositions and methods of use
|
PE20191846A1
(es)
|
2017-06-02 |
2019-12-31 |
Pfizer |
Anticuerpos especificos para flt3 y sus usos
|
WO2018231771A1
(en)
|
2017-06-13 |
2018-12-20 |
Bostongene Corporation |
Systems and methods for generating, visualizing and classifying molecular functional profiles
|
EP3651799A1
(de)
|
2017-07-13 |
2020-05-20 |
Massachusetts Institute of Technology |
Targeting des hdac2-sp3-komplexes zur verbesserung der synaptischen funktion
|
WO2019016784A1
(en)
|
2017-07-21 |
2019-01-24 |
Universidade De Coimbra |
ANTI-NUCLEOLIN ANTIBODIES
|
WO2019070161A2
(en)
|
2017-10-04 |
2019-04-11 |
Opko Pharmaceuticals, Llc |
ARTICLES AND METHODS FOR PERSONALIZED THERAPY OF CANCER
|
AU2019215075A1
(en)
|
2018-02-01 |
2020-08-20 |
Pfizer Inc. |
Antibodies specific for CD70 and their uses
|
KR20200128018A
(ko)
|
2018-02-01 |
2020-11-11 |
화이자 인코포레이티드 |
Cd70을 표적으로 하는 키메라 항원 수용체
|
JP2021516045A
(ja)
|
2018-02-28 |
2021-07-01 |
ファイザー・インク |
Il−15バリアントおよびその使用
|
TWI816396B
(zh)
|
2018-05-23 |
2023-09-21 |
美商輝瑞大藥廠 |
特異性針對gucy2c之抗體及其用途
|
TWI793325B
(zh)
|
2018-05-23 |
2023-02-21 |
美商輝瑞大藥廠 |
對cd3具特異性之抗體及其用途
|
US20210005284A1
(en)
|
2019-07-03 |
2021-01-07 |
Bostongene Corporation |
Techniques for nucleic acid data quality control
|
US20220273568A1
(en)
*
|
2019-07-12 |
2022-09-01 |
Pacira Pharmaceuticals, Inc. |
Multivesicular liposome formulations of dexmedetomidine
|
EP4007576A4
(de)
*
|
2019-08-01 |
2023-05-10 |
InCarda Therapeutics, Inc. |
Antiarrhythmische formulierung
|
US11020384B2
(en)
|
2019-08-01 |
2021-06-01 |
Incarda Therapeutics, Inc. |
Antiarrhythmic formulation
|
US11788091B2
(en)
|
2019-08-21 |
2023-10-17 |
University Of Virginia Patent Foundation |
Methods and compositions for diagnosing and treating prostate cancer based on long noncoding RNA overlapping the LCK gene that regulates prostate cancer cell growth
|
EP4041308A1
(de)
|
2019-10-07 |
2022-08-17 |
University of Virginia Patent Foundation |
Modulation von lymphgefässen bei neurologischen erkrankungen
|
EP4041312A4
(de)
|
2019-10-10 |
2023-12-20 |
Kodiak Sciences Inc. |
Verfahren zur behandlung einer augenstörung
|
WO2021072244A1
(en)
|
2019-10-11 |
2021-04-15 |
Beth Israel Deaconess Medical Center, Inc. |
Anti-tn antibodies and uses thereof
|
BR112022013784A2
(pt)
|
2020-01-13 |
2022-10-11 |
Durect Corp |
Sistemas de distribuição de fármacos de liberação prolongada com impurezas reduzidas e métodos relacionados
|
EP4093426A1
(de)
|
2020-01-24 |
2022-11-30 |
University of Virginia Patent Foundation |
Modulation von lymphgefässen bei neurologischen erkrankungen
|
WO2021205325A1
(en)
|
2020-04-08 |
2021-10-14 |
Pfizer Inc. |
Anti-gucy2c antibodies and uses thereof
|
WO2021224850A1
(en)
|
2020-05-06 |
2021-11-11 |
Crispr Therapeutics Ag |
Mask peptides and masked anti-ptk7 antibodies comprising such
|
AU2021308586A1
(en)
|
2020-07-17 |
2023-03-02 |
Pfizer Inc. |
Therapeutic antibodies and their uses
|
JP2023535604A
(ja)
|
2020-07-30 |
2023-08-18 |
ファイザー・インク |
遺伝子複製を有する細胞およびその使用
|
EP4203989A2
(de)
|
2020-09-03 |
2023-07-05 |
Rampart Bioscience, Inc. |
Lösliche alkalische phosphatasekonstrukte und expressionsvektoren mit einem polynukleotid zur codierung löslicher alkalischer phosphatasekonstrukte
|
US20220180972A1
(en)
|
2020-12-04 |
2022-06-09 |
Bostongene Corporation |
Hierarchical machine learning techniques for identifying molecular categories from expression data
|
US11357727B1
(en)
|
2021-01-22 |
2022-06-14 |
Pacira Pharmaceuticals, Inc. |
Manufacturing of bupivacaine multivesicular liposomes
|
US11033495B1
(en)
|
2021-01-22 |
2021-06-15 |
Pacira Pharmaceuticals, Inc. |
Manufacturing of bupivacaine multivesicular liposomes
|
US11278494B1
(en)
|
2021-01-22 |
2022-03-22 |
Pacira Pharmaceuticals, Inc. |
Manufacturing of bupivacaine multivesicular liposomes
|
JP2024517745A
(ja)
|
2021-04-29 |
2024-04-23 |
ボストンジーン コーポレイション |
複合腫瘍組織における腫瘍細胞発現を推定するための機械学習技法
|
CA3227875A1
(en)
|
2021-08-02 |
2023-02-09 |
Pfizer Inc. |
Improved expression vectors and uses thereof
|
WO2023147177A1
(en)
|
2022-01-31 |
2023-08-03 |
Bostongene Corporation |
Machine learning techniques for cytometry
|
WO2023148598A1
(en)
|
2022-02-02 |
2023-08-10 |
Pfizer Inc. |
Cysteine prototrophy
|
WO2024015561A1
(en)
|
2022-07-15 |
2024-01-18 |
Bostongene Corporation |
Techniques for detecting homologous recombination deficiency (hrd)
|
CN115486539A
(zh)
*
|
2022-09-14 |
2022-12-20 |
厦门遇见今生生物科技有限公司 |
具有抗衰老及端粒延长的草药提取物仿生膜及其制备方法
|